Macro Finance
India’s Cheap Weight-Loss Drugs Get A Reality Check
Bloomberg Markets·August 28, 2026·1 min read
Cheaper weight-loss drugs were expected to take off in India, but demand has been slower than expected despite GLP-1s costing as little as $14 a month. Satviki Sanjay explains that stigma and hesitant doctors are key barriers, showing price isn't the only obstacle to adoption in the market.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.